U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Science & Research
  3. Science and Research Special Topics
  4. Advancing Regulatory Science
  5. Focus Areas of Regulatory Science Report
  6. Cross-cutting Topics: Minority Health and Health Equity Regulatory Science Research
  1. Focus Areas of Regulatory Science Report

Cross-cutting Topics: Minority Health and Health Equity Regulatory Science Research

Per a court order, HHS is required to restore this website as of 11:59 PM on February 14, 2025. Any information on this page promoting gender ideology is extremely inaccurate and disconnected from the immutable biological reality that there are two sexes, male and female. The Trump Administration rejects gender ideology and condemns the harms it causes to children, by promoting their chemical and surgical mutilation, and to women, by depriving them of their dignity, safety, well-being, and opportunities. This page does not reflect biological reality and therefore the Administration and this Department reject it.

Three scientist in a lab

FDA’s Office of Minority Health and Health Equity (OMHHE) leads efforts to advance minority health and health equity- focused regulatory science research. To support research efforts, OMHHE engages across all FDA product centers and offices, as well as a broad range of stakeholders, including academia, minority-serving institutions, government agencies, and non-profit organizations.

OMHHE leverages various funding mechanisms, collaborations, and partnerships to advance its mission by establishing new scientific initiatives and supporting novel health disparity and health equity-focused intramural and extramural research. The OMHHE Challenge Grants support intramural research in collaboration with FDA scientists. The OMHHE extramural research program supports extramural research in collaboration with diverse organizations through OMHHE Innovation Award grants, the Broad Agency Announcements, the Centers of Excellence in Regulatory Science and Innovation, Research Collaboration Agreements, and Inter-Agency Agreements.

OMHHE advances regulatory science by supporting research that contributes to the reduction of health disparities and advancement of health equity. For example, supporting research that contributes to advancing inclusion of racial and ethnic minority populations in clinical trials, and the continued evaluation of FDA regulated products by demographic data including, but not limited to, ethnicity, race, age, and geography. OMHHE also advances scientific workforce diversity by supporting post-doctoral fellowship programs such as the Genomic Science and Health Equity (GSHE) Postdoctoral Fellowship, a joint program with the FDA OMHHE and the National Human Genome Research Institute (NHGRI) at the National Institutes of Health (NIH).

OMHHE Mission
The FDA Office of Minority Health and Health Equity (OMHHE) works to promote and protect the health of diverse populations through research and communication that addresses health disparities. OMHHE serves as the principal advisor to the Commissioner and other key officials on scientific and policy issues relating to the health of racial and ethnic minorities, and other underrepresented or underserved populations. OMMHE advocates, collaborates, and partners within and outside FDA for the participation of racial and ethnic minorities, and other diverse populations in clinical trials. OMHHE also supports activities to expand language access.

 

 

 

CROSS-CUTTING TOPICS

Minority Health and Health EquityWomen’s HealthMaternal HealthPediatric Health
OncologyRare DiseasesOne Health Initiative 

 

 

Research Capabilities, Tools, and Resources

Research Management and CollaborationsTechnology Transfer and Public-Private PartnershipsPhysical Standards and Reference MaterialsIntramural Grant ProgramsExtramural Funding Mechanisms

Scientific Education, Training, and Communication

Fellowship and Training OpportunitiesProfessional Development and Continuing EducationCommunication and External Meetings

Infrastructure

Facilities and Shared ResourcesSafety and Compliance

 

ADDITIONAL ORGANIZATIONAL INFORMATION

Office of the Chief ScientistOffice of Regulatory Science and InnovationContact Us: FARS@fda.hhs.gov

 

Back to Top